Jiménez-Vicente, C., Othman, J., Potter, N., Jovanovic, J., Runglall, M., Aucken, P., Barr, L., O’Sullivan, J., de Lavallade, H., Lim, M., Harrington, P., Russell, N. and Dillon, R. (2020) “Blinatumomab for measurable residual disease relapse in acute myeloid leukemia with t(8;21) translocation: the BlinAML Trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301120.